NORDIC BIOSCIENCE HOLDING A/S — Credit Rating and Financial Key Figures
CVR number: 30511271
Herlev Hovedgade 205, 2730 Herlev
info@nordicbio.com
tel: 44525252
www.nordicbioscience.com
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 237.94 | 224.98 | 293.74 | 190.45 | 527.39 |
Other operating income | 2.36 | 10.82 | 8.44 | ||
Costs of manufacturing | -58.03 | -61.83 | |||
Gross profit | 237.94 | 224.98 | 296.10 | 132.42 | 465.56 |
Costs of management | -49.16 | -76.95 | |||
Employee benefit expenses | - 105.16 | ||||
Other operating expenses | - 158.31 | - 187.62 | - 139.99 | - 111.71 | - 199.32 |
EBIT | 79.63 | 37.36 | 50.95 | -17.63 | 197.73 |
Other financial income | 0.65 | 4.46 | 16.08 | ||
Other financial expenses | -7.98 | -4.00 | |||
Pre-tax profit | 79.63 | 37.36 | 51.60 | -21.16 | 209.81 |
Income taxes | 33.47 | -38.99 | |||
Net earnings | 79.63 | 37.36 | 51.60 | 12.31 | 170.81 |
Assets (mDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Intangible rights | 8.42 | 7.97 | 4.06 |
Intangible assets total | 8.42 | 7.97 | 4.06 |
Buildings | 66.93 | 65.64 | 64.29 |
Other tangible assets | 9.16 | 13.18 | 10.87 |
Tangible assets total | 76.09 | 78.81 | 75.15 |
Other non-current investments | 0.00 | ||
Investments total | 0.00 | ||
Deferred tax assets | 42.00 | 67.78 | |
Long term receivables total | 42.00 | 67.78 | |
Inventories total | 27.41 | 23.61 | 19.94 |
Current trade debtors | 38.37 | 21.24 | 82.91 |
Current owed by particip. interest comp. | 3.08 | 2.86 | |
Prepayments and accrued income | 4.34 | 12.68 | 13.44 |
Current other receivables | 9.93 | 17.41 | 1.62 |
Short term receivables total | 55.72 | 54.19 | 97.97 |
Cash and bank deposits | 60.62 | 81.95 | 455.42 |
Cash and cash equivalents | 60.62 | 81.95 | 455.42 |
Balance sheet total (assets) | 228.26 | 288.54 | 720.32 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 10.62 | 10.62 | 10.62 | ||
Other reserves | 137.13 | 57.77 | -1.29 | 3.79 | 3.75 |
Retained earnings | -79.63 | -37.36 | 0.71 | 17.35 | 45.77 |
Profit of the financial year | 79.63 | 37.36 | 51.60 | 12.31 | 170.81 |
Shareholders equity total | 137.13 | 57.77 | 61.64 | 44.07 | 230.95 |
Provisions | 2.95 | ||||
Non-current leasing loans | 3.07 | 2.40 | |||
Non-current other liabilities | 42.17 | 39.80 | 37.04 | ||
Non-current deferred tax liabilities | 2.95 | 3.26 | 1.21 | ||
Non-current liabilities total | 45.12 | 46.12 | 40.65 | ||
Current leasing loans | 0.51 | 0.67 | |||
Current trade creditors | 29.23 | 15.26 | 37.48 | ||
Short-term deferred tax liabilities | 3.13 | 7.55 | 65.63 | ||
Other non-interest bearing current liabilities | - 137.13 | -57.77 | 8.39 | 8.32 | 7.43 |
Accruals and deferred income | 80.75 | 166.70 | 337.51 | ||
Current liabilities total | - 137.13 | -57.77 | 121.51 | 198.34 | 448.72 |
Balance sheet total (liabilities) | 231.21 | 288.54 | 720.32 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.